Ovarian Cancer
Artificial intelligence model predicts treatment response in ovarian cancer
A trained artificial intelligence model predicted treatment outcomes before surgery of women with high-grade serous ovarian cancer, according to study results.
Q&A: Researchers find genetic link between endometriosis, ovarian cancer
Data published in Cell Reports Medicine showed that endometriosis was genetically linked to ovarian cancer.
32% of older women who survived certain cancers report lower extremity lymphedema
Nearly one-third of older women who survived colorectal, endometrial or ovarian cancer reported lower extremity lymphedema, according to data published in JAMA Network Open.
Hyperthermic intraperitoneal chemotherapy may benefit some women with ovarian cancer
Adding hyperthermic intraperitoneal chemotherapy to cytoreductive surgery did not significantly prolong PFS or OS among women with advanced epithelial ovarian cancer, according to a single-blind, randomized study in JAMA Surgery.
Paclitaxel plus carboplatin ’preferred regimen of choice’ for gynecologic carcinosarcomas
Paclitaxel plus carboplatin demonstrated noninferiority to paclitaxel plus ifosfamide and should be a standard treatment for uterine carcinosarcoma, according to results of a phase 3 study published in Journal of Clinical Oncology.
Germline BRCA testing underused for women with ovarian cancer and commercial insurance
About one-third of women with commercial insurance underwent genetic testing for ovarian cancer between 2008 and 2018 despite unequivocal recommendations for universal testing, according to research in JAMA Network Open.
High platelet count associated with increased risk for certain cancers
Individuals with an increased platelet count demonstrated an increased risk for cancer, with the association especially strong in colon, lung, ovarian and stomach cancers, according to a nested case-control study in JAMA Network Open.
2021’s top stories about breast, cervical and ovarian cancer research
COVID-19 dominated headlines in 2021, but breast, cervical and ovarian cancers remain leading causes of mortality among women. Here are our top stories about new research designed to save lives for the year.
Top in hem/onc: Cash balance plans, physician-patient relationships
The pension plan known as a cash balance plan may help physicians reduce their practices’ and their own taxable income. A review of how this plan works and its potential benefits was the top story in hematology/oncology last week.
Cytoreductive surgery before chemotherapy benefits women with recurrent ovarian cancer
Cytoreductive surgery before chemotherapy led to significant and clinically meaningful OS and PFS benefits for women with recurrent ovarian cancer, according to a phase 3 study published in The New England Journal of Medicine.